News Tag: 2022 newsletters
Testing the addition of trastuzumab or trastuzumab/pertuzumab to the usual chemotherapy for HER2 positive uterine serous or carcinosarcoma (NRG-GY026)
Read More
Summer Meeting 2022 Protocol Support Committee (PSC) Wrap Up
Read More
FORTE Study Updates: Natural Language Processing Update
Read More
Adding Stereotactic Radiation Therapy to Immune Therapy for Patients with Advanced Renal Cell Cancer (NRG-GU012, The “SAMURAI” Study)
Read More
IACRN: International Association of Clinical Research Nurses
Read More
NRG NCORP Selects CCDR Pilot Project Awardee
Read More
Join FORTE at the NRG Oncology Semiannual Meeting!
Read More
The Vision of Remote Auditing and Monitoring
Read More
NRG-CC005 (FORTE) Breaking News! Welcome to the FORTE Education and Communication Specialist
Read More
Preparing for the NRG Quality Assurance Audit
Read More